A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

NCT00562783 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis B
Hepatitis C
Liver Cirrhosis

Interventions

DRUG: Vitaliver
DRUG: Placebo

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]